This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Kanoncure, Inc., Tottori University, National University Corporation Tottori University. Active years: 2020-2025.
Company Filing History:
3 out of 4 
2 out of 61 
1 out of 4 Years Active: 2020-2025
Title: The Innovative Contributions of Yohei Kouno
Introduction
Yohei Kouno is a notable inventor based in Yonago, Japan. He has made significant contributions to the field of therapeutic drugs, particularly in the treatment of malignant tumors and fibrosis. With a total of 3 patents to his name, Kouno's work is paving the way for advancements in cancer treatment.
Latest Patents
Kouno's latest patents focus on the inhibitory effects of low molecular weight compounds on cancer and fibrosis. His innovative approach has led to the development of a novel therapeutic drug aimed at malignant tumors and cancer stem cells. This drug includes at least one compound selected from a specific group of formulas, along with its salts or solvates. Additionally, he has explored therapeutic options for fibrosis using similar compounds, showcasing his versatility in addressing complex medical challenges.
Career Highlights
Throughout his career, Kouno has worked with prominent organizations such as Kanoncure, Inc. and Tottori University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in therapeutic drug development.
Collaborations
Kouno has collaborated with notable colleagues, including Goshi Shiota and Noriko Itaba. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yohei Kouno's innovative work in the field of therapeutic drugs demonstrates his commitment to improving cancer treatment and addressing significant medical issues. His contributions are invaluable to the scientific community and hold promise for future advancements in healthcare.